CatalystPit

CRDFCardiff Oncology, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $1.21 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$94.13M
CountryUSA
RECENT INSIDER TRADES
  • 2026-07-16 · Mohindru Mani (Chief Executive Officer) · BUY
  • 2026-07-16 · PACE GARY W (Director) · BUY
  • 2026-06-22 · Mohindru Mani (Chief Executive Officer) · BUY
  • 2026-06-22 · PACE GARY W (Director) · BUY
  • 2025-07-31 · PACE GARY W (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders114
Shares held26,211,890
Value$43.64M
Percent of shares outstanding33.69%
As of quarter end2026-06-30
RECENT NEWS
  • Cardiff Oncology and Nerviano Medical Sciences amend 2017 license agreement
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Cardiff Oncology, Inc. (CRDF) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit